| Literature DB >> 25764298 |
S Palakodeti1, C S Uratsu2, J A Schmittdiel2, R W Grant2.
Abstract
AIMS: To identify the predictors and clinical effects among inactive patients with diabetes who become physically active, in the setting of a large integrated health system.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25764298 PMCID: PMC5008143 DOI: 10.1111/dme.12748
Source DB: PubMed Journal: Diabet Med ISSN: 0742-3071 Impact factor: 4.359
Baseline patient characteristics by level of moderate‐to‐vigorous physical activity achieved
| Moderate‐to‐vigorous physical activity level |
| |||
|---|---|---|---|---|
| No increase: 62.5%, | Some increase: 21.6%, | Recommended level: 16.0%, | ||
| Patient demographics | ||||
| Female, | 2262 (52.9) | 779 (52.7) | 481 (43.9) | < 0.001 |
| Mean ( | 60.7 (9.98) | 59.73 (10.22) | 58.87 (10.45) | < 0.001 |
| Age group, | ||||
| 30–39 years | 103 (2.4) | 52 (3.5) | 36 (3.3) | |
| 40–49 years | 466 (10.9) | 173 (11.7) | 130 (11.9) | |
| 50–59 years | 1142 (26.7) | 423 (28.6) | 323 (29.5) | |
| 60–69 years | 1641 (38.3) | 551 (37.3) | 424 (38.7) | |
| 70–75 years | 898 (21.0) | 269 (18.2) | 168 (15.3) | |
| Race/ethnicity, | ||||
| White | 2039 (47.6) | 682 (46.2) | 461 (42.1) | < 0.001 |
| Black | 426 (10.0) | 142 (9.6) | 99 (9.0) | |
| Asian | 624 (14.6) | 304 (20.6) | 226 (20.6) | |
| Hispanic | 964 (22.5) | 268 (18.1) | 240 (21.9) | |
| Other | 227 (5.3) | 81 (5.5) | 70 (6.4) | |
| Income, | ||||
| < $40k | 897 (22.4) | 246 (18.0) | 212 (20.8) | < 0.001 |
| $40k to < $75k | 2321 (57.9) | 789 (57.6) | 558 (54.7) | |
| ≥ $75k | 793 (19.8) | 335 (24.5) | 250 (24.5) | |
| Education: Bachelor degree, | ||||
| < 10% | 1088 (27.1) | 305 (22.3) | 248 (24.3) | < 0.001 |
| 10–19% | 1470 (36.6) | 473 (34.5) | 345 (33.8) | |
| 20–29% | 1003 (25.0) | 400 (29.2) | 279 (27.4) | |
| ≥ 30% | 450 (11.2) | 192 (14.0) | 148 (14.5) | |
| Clinical characteristics | ||||
|
Mean ( | 59.8 (17.1) | 59.7 (16.4) | 60.3 (18.6) | 0.63 |
| HbA1c concentration, | 7.62 (1.56) | 7.61 (1.50) | 7.67 (1.70) | 0.22 |
| < 53 mmol/mol (7%) | 1717 (41.2) | 573 (40.0) | 431 (40.7) | |
| 53–62.8 mmol/mol (7–7.9%) | 1186 (28.5) | 463 (32.3) | 315 (29.7) | |
| 63.9–73.8 mmol/mol (8–8.9%) | 573 (13.8) | 181 (12.6) | 144 (13.6) | |
| ≥ 74.9 mmol/mol (9%) | 690 (16.6) | 216 (15.1) | 169 (16.0) | |
| Mean ( | 34.42 (7.76) | 33.36 (7.50) | 32.29 (6.96) | < 0.001 |
| BMI, | ||||
| 19–24.9 kg/m2 | 333 (7.8) | 156 (10.6) | 138 (12.7) | < 0.001 |
| 25–29.9 kg/m2 | 1018 (23.9) | 393 (26.8) | 312 (28.6) | |
| 30–34.99 kg/m2 | 1158 (27.2) | 398 (27.1) | 321 (29.4) | |
| ≥ 35 kg/m2 | 1745 (41.0) | 520 (35.4) | 319 (29.3) | |
| Comorbidities, | ||||
| Cerebrovascular disease | 849 (19.8) | 239 (16.2) | 177 (16.1) | 0.001 |
| Chronic obstructive pulmonary disease /asthma | 680 (15.9) | 210 (14.2) | 115 (10.5) | < 0.001 |
| Chronic kidney disease | 985 (23.0) | 302 (20.4) | 179 (16.3) | < 0.001 |
| Depression | 745 (17.4) | 212 (14.4) | 120 (10.9) | < 0.001 |
| Medications, | ||||
| Diabetic | 3728 (87.1) | 1269 (85.9) | 927 (84.6) | 0.075 |
| Antidepressant | 1278 (29.7) | 388 (26.3) | 231 (21.1) | < 0.001 |
| Exercise‐related documentation in physician progress note, | 1,346 (31.4) | 490 (33.2) | 374 (34.1) | 0.165 |
| Lifestyle‐related referral, | 215 (5.0) | 94 (6.4) | 80 (7.3) | 0.006 |
Recommended moderate‐to‐vigorous physical activity: ≥ 150 min/week.
Some increase in moderate‐to‐vigorous physical activity: moderate‐to‐vigorous physical activity of < 150 min/week.
Income and education measures represent neighbourhood prevalence based on 2010 Census tract data and patient residence.
Independent predictors of becoming physically active among inactive patients
| Moderate‐to‐vigorous physical activity/week: < 10 vs. ≥ 10 min |
| Moderate‐to‐vigorous physical activity/week: < 150 vs. ≥ 150 min |
| |
|---|---|---|---|---|
| Gender: female | 0.93 | 0.16 | 0.77 | < 0.001 |
| Race/ethnicity | ||||
| White | 1 (referent) | 1 (referent) | ||
| Black | 1.001 | 0.99 | 0.99 | 0.97 |
| Asian | 1.18 | 0.04 | 1.07 | 0.51 |
| Hispanic | 0.88 | 0.07 | 1.07 | 0.46 |
| BMI | ||||
| 1 –24.9 kg/m2 | 1 (ref) | 1 (ref) | ||
| 25–29.9 kg/m2 | 0.85 | 0.09 | 0.80 | 0.07 |
| 30–34.9 kg/m2 | 0.77 | 0.01 | 0.76 | 0.03 |
| ≥ 35 kg/m2 | 0.62 | < 0.001 | 0.55 | < 0.001 |
| HbA1c at baseline | ||||
| < 7.0 | 1 (referent) | 1 (referent) | ||
| 7–7.9 | 1.13 | 0.05 | 1.01 | 0.95 |
| 8–8.9 | 0.97 | 0.67 | 0.99 | 0.93 |
| ≥ 9.0 | 0.92 | 0.30 | 0.93 | 0.48 |
| Chronic kidney disease | 0.88 | 0.07 | 0.78 | 0.01 |
| Depression | 0.82 | 0.01 | 0.77 | 0.02 |
| Referred to lifestyle education class | 1.40 | 0.002 | 1.42 | 0.01 |
Change in weight and HbA1c among patients who became physically active relative to patients remaining physically inactive
| Weight change, kg ( |
| HbA1c change ( |
| HbA1c change [Baseline HbA1c ≥ 53 mmol/mol (7%)] |
| |
|---|---|---|---|---|---|---|
| Moderate‐to‐vigorous physical activity level at follow‐up | ||||||
| 0–149 min/week | −0.13 | 0.32 | 0.06% | 0.39 | 0.02% | 0.84 |
| ≥ 150 min/week | −1.07 | < .001 | −0.08% | 0.32 | −0.18% | 0.09 |
Patients remaining physically inactive were the referent group. Values were adjusted for baseline patient differences.
A total of 1822 patients in the cohort had two HbA1c measurements during the study period, including 1175 patients who had HbA1c ≥ 53 mmol/mol at baseline.